Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCity Lon Inv Regulatory News (CLIG)

Share Price Information for City Lon Inv (CLIG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 360.00
Bid: 351.00
Ask: 366.00
Change: 2.00 (0.56%)
Spread: 15.00 (4.274%)
Open: 358.00
High: 360.00
Low: 358.00
Prev. Close: 358.00
CLIG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

17 Jan 2018 07:00

RNS Number : 0648C
City of London Investment Group PLC
17 January 2018
 

RNS Number:

City of London Investment Group PLC

17 January 2018



CITY OF LONDON INVESTMENT GROUP PLC

("City of London", "the Group" or "the Company")

 

FUNDS UNDER MANAGEMENT AS AT 31 December 2017,

TRADING UPDATE

 

City of London (LSE: CLIG) announces that total funds under management (FuM) at the Group's half year on 31 December 2017 were US$5.3 billion (£3.9 billion). This compares with US$4.7 billion (£3.6 billion) at the Company's year-end on 30 June 2017. A breakdown by strategy follows:

 

FuM ($mn)

Strategy Index

Jun-17

Dec-17

% inc /

Net

% inc /

(estimate)

dec

Flows

dec

EM

4,202

4,660

11%

(89)

MSCI EM

16%

DEV

179

337

88%

129

MSCI ACWI

11%

GTAA

110

139

26%

20

ACWI/Barclays Global Agg

7%

Frontier

172

193

12%

2

MSCI Frontier

12%

4,663

5,329

62

 

 

Positive relative investment performance was recorded across Developed, GTAA and Frontier strategies. Generally, a combination of strong NAV performance, discount narrowing and opportunistic participation in event driven US situations drove relative performance. The EM strategy underperformed due to widening discounts and an underweight to the Chinese IT sector which posted very strong returns. Net flows were positive in aggregate over the period, particularly in the Developed strategy which continues to benefit from a focused marketing strategy and excellent long term investment results.

 

In addition, we have to date received notification of $110 million net inflows in aggregate across all strategies, which we expect to fund over the next quarter.

 

With regards to business development, the Group continues to maintain an active pipeline across all of its major CEF offerings with an increased interest in the diversification CEF strategies. In total the active pipeline is in excess of US$400 million, these include opportunities that are spread across Emerging and Developed Markets, Global Tactical Asset Allocation, Tactical Income, and Frontier CEF strategies.

 

Operations

 

The Group's income currently accrues at a weighted average rate of approximately 82 basis points of FuM, net of third party commissions. "Fixed" costs are c£1.0 million per month, and accordingly the current run-rate for operating profit, before profit-share of 30% and an estimated EIP charge of 2%, is approximately £1.7 million per month based upon current FuM and a US$/£ exchange rate of US$1.35 to £1 as at 31 December 2017.

 

The Group estimates the unaudited profit before taxation for the six months ended 31 December 2017 to be approximately £6.6 million, which compares with £5.8 million for the equivalent period to 31 December 2016.

 

The Company is currently in a close period which will end with the publication of results for the six months ended 31 December 2017 on 19 February 2018.

 

Dividend

 

The Board has decided to declare an interim dividend of 9 pence (2017: 8 pence). The dividend will be paid on 16 March 2018 to shareholders registered at the close of business on 2 March 2018.

 

 

Template

 

Please see the attached graph which is based on the following assumptions and includes the estimated quarterly cost of a maintained dividend:

 

http://www.rns-pdf.londonstockexchange.com/rns/0648C_1-2018-1-16.pdf

 

Key assumptions:

 

(June 2017 comparatives in Italics)

· Starting point Current FuM (end December 2017)

· Net increase for the remainder of this financial year (straight-lined to June 2018):

- emerging market CEF strategy US$100m (US$250m over full year)

- non-emerging market CEF strategies US$125 (US$250m over full year)

· Net increase in 2018/2019 (straight-lined to June 2019):

- emerging market CEF strategy US$100m

- non-emerging market CEF strategies US$250m

· Operating margin adjusted monthly for change in product mix and commission run-off

· Market growth: 0%

· Overheads for 2017/18: +4% compared to 2016/17 (+3%)

· Overheads for 2018/19: +7% compared to 2016/17

· EIP cost for 2017/18: 2% of operating profit (2%)

· EIP cost for 2018/19: 4% of operating profit

· Corporation tax based on an estimated average rate of 23% (23%)

· Exchange rate assumed to be £1/$1.35 for entire period (£1/US$1.30)

· Number of CLIG Shares in issue (26.9m) less those held by the ESOP Trust (1.4m) as at 31 December (26.9m CLIG shares in issue less 1.5m ESOP Trust holding)

 

For further information, please visit http://www.citlon.co.uk/ or contact:

 

Barry Olliff, CEO

City of London Investment Group PLC

Tel: 001 215 313 3774

 

Martin Green

Zeus Capital Limited

Financial Adviser & Broker

Tel: +44 (0)20 3829 5000

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTSFUFAMFASEDF
Date   Source Headline
20th Feb 20094:09 pmRNSDividend reinvestment plan
11th Feb 20094:55 pmRNSHolding(s) in Company
9th Feb 200911:03 amRNSDirector/PDMR Shareholding
4th Feb 20093:16 pmRNSDirector/PDMR Shareholding
4th Feb 200912:04 pmRNSHolding(s) in Company
30th Jan 20099:32 amRNSTotal Voting Rights
28th Jan 20094:02 pmRNSDirector/PDMR Shareholding & TVR
28th Jan 20097:00 amRNSHalf Yearly Report
21st Jan 200912:16 pmRNSHolding(s) in Company
13th Jan 20099:00 amRNSBlock Admission & TVR
8th Dec 20087:34 amRNSFunds under Management - Replacement
8th Dec 20087:00 amRNSFunds Under Management
27th Nov 20084:31 pmRNSDirector/PDMR Shareholding
7th Nov 20089:09 amRNSDirector/PDMR Shareholding
3rd Nov 20087:00 amRNSChange of Registered Office
28th Oct 20087:00 amRNSResult of AGM
27th Oct 20087:00 amRNSAGM Trading Update
8th Oct 200810:01 amRNSChange of Adviser Name
30th Sep 200812:18 pmRNSDirector/PDMR Shareholding
30th Sep 200810:04 amRNSDirector/PDMR Shareholding
22nd Sep 20081:04 pmRNSNotifiable Interest
15th Sep 20087:00 amRNSFinal Results
14th Jul 20086:03 pmRNSDirector/PDMR Shareholding
10th Jun 20087:00 amRNSDirector/PDMR Shareholding
9th Jun 20087:00 amRNSTrading Update
19th May 20082:34 pmRNSDirectorate Change
28th Apr 20083:50 pmRNSNotifiable Interest
23rd Apr 20087:00 amRNSNotifiable Interest
18th Apr 20085:00 pmRNSNotifiable Interest
18th Apr 20083:36 pmRNSDirector/PDMR Shareholding
31st Mar 20089:56 amRNSTotal Voting Rights
27th Mar 20087:01 amRNSDirector/PDMR Shareholding
26th Mar 20082:24 pmRNSAppointment of Joint Broker
17th Mar 200810:51 amRNSNotifiable Interest
10th Mar 20087:00 amRNSFunds Under Management
29th Feb 20085:01 pmRNSNotifiable Interest
29th Feb 20085:00 pmRNSNotifiable Interest
29th Feb 20087:01 amRNSBuyback & Directors' Dealing
7th Feb 20089:57 amRNSDirector/PDMR Shareholding
6th Feb 20087:01 amRNSDirector/PDMR Shareholding
29th Jan 20087:00 amRNSInterim Results
18th Jan 200811:47 amRNSNotice of Results Correction
18th Jan 20089:07 amRNSNotice of Results
10th Dec 20077:00 amRNSFunds Under Management
30th Nov 20077:01 amRNSDirector/PDMR Shareholding
29th Oct 200712:44 pmRNSResult of AGM
29th Oct 20077:00 amRNSTrading Update
24th Sep 20073:38 pmRNSDirector/PDMR Shareholding
19th Sep 20074:32 pmRNSDirector/PDMR Shareholding
17th Sep 20077:01 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.